Qingdao Vland Biotech Co., Ltd. (603739) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Qingdao Vland Biotech Co., Ltd.

Why is Qingdao Vland Biotech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 8.40% and Operating profit at 1.41% over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

DEBTORS TURNOVER RATIO(HY) Lowest at 3.2 times
OPERATING PROFIT(Q) Lowest at CNY 27.06 MM
OPERATING PROFIT MARGIN(Q) Lowest at 7.44 %

With ROE of 4.90%, it has a expensive valuation with a 1.99 Price to Book Value

Over the past year, while the stock has generated a return of 15.88%, its profits have fallen by -13.3%
At the current price, the company has a high dividend yield of 0.6

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Qingdao Vland Biotech Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Qingdao Vland Biotech Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Qingdao Vland Biotech Co., Ltd.

-3.42%

0.27

36.42%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.29%

EBIT Growth (5y)

-5.85%

EBIT to Interest (avg)

20.12

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

0.14

Sales to Capital Employed (avg)

0.53

Tax Ratio

25.12%

Dividend Payout Ratio

36.25%

Pledged Shares

Institutional Holding

ROCE (avg)

7.16%

ROE (avg)

7.19%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.49

EV to EBIT

32.01

EV to EBITDA

15.95

EV to Capital Employed

1.44

EV to Sales

2.06

PEG Ratio

Dividend Yield

0.81%

ROCE (Latest)

4.49%

ROE (Latest)

4.50%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -12.43% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 11.28 %

PRE-TAX PROFIT(Q)

Highest at CNY 32.23 MM

NET PROFIT(Q)

Highest at CNY 17.87 MM

-9What is not working for the Company

INTEREST(HY)

At CNY 10.96 MM has Grown at 11.97%

OPERATING CASH FLOW(Y)

Lowest at CNY 130.9 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 530.56

OPERATING PROFIT(Q)

Lowest at CNY 28.5 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.26 %

Here's what is working for Qingdao Vland Biotech Co., Ltd.

Pre-Tax Profit

Highest at CNY 32.23 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 17.87 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 17.87 MM has Grown at 86.6%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at 11.28 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -12.43% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Qingdao Vland Biotech Co., Ltd.

Interest

At CNY 10.96 MM has Grown at 11.97%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 530.56

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at CNY 130.9 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 28.5 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 8.26 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales